- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
March 30, 2023Minnesota Attorney General Keith Ellison and Robins Kaplan Partner Tara Sutton Give Opening Statements in Minnesota’s Lawsuit Against JUUL
March 28, 2023Robins Kaplan LLP Announces 2023 Leadership Council on Legal Diversity (LCLD) Fellow and Pathfinder
March 22, 2023Benchmark Litigation Names Robins Kaplan 2023 Minnesota Law Firm of the Year
April 3, 2023Conference of Tribal Lending Commissioners
April 11-13, 2023Mass Torts Made Perfect Seminar
April 19, 2023FBA Women in MDL, Mass and Class Leadership
March 2023Unintended Consequences of Banning Noncompete Agreements
March 26, 2023What I’ll Be Watching for in the Amgen Oral Arguments
March 2023How an Investor Can Lose More Than Just Their Investment
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Rogue Employees and Protecting your Company Trade Secrets and Confidential Information
December 19, 2017
In recent years, a greater awareness has emerged for protecting company intellectual property (IP) with complimentary trade secret and patent protection plans. This awareness is driven in part by the Defend Trade Secrets Act of 2016, which created a federal civil cause of action for trade secret misappropriation, and the increased scrutiny being placed on patents by the America Invents Act and case law addressing patent eligibility.
Originally published in The Pharma Letter, December 19, 2017
The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.